Cargando…
High prevalence of MAP2K1 mutations in variant and IGHV4-34 expressing hairy-cell leukemia
Autores principales: | Waterfall, Joshua J., Arons, Evgeny, Walker, Robert L., Pineda, Marbin, Roth, Laura, Killian, J. Keith, Abaan, Ogan D., Davis, Sean R., Kreitman, Robert J., Meltzer, Paul S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905739/ https://www.ncbi.nlm.nih.gov/pubmed/24241536 http://dx.doi.org/10.1038/ng.2828 |
Ejemplares similares
-
Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues
por: Kreitman, Robert J., et al.
Publicado: (2022) -
Development of Recombinant Immunotoxins for Hairy Cell Leukemia
por: Kreitman, Robert J., et al.
Publicado: (2020) -
Expression of the muscle-associated gene MYF6 in hairy cell leukemia
por: Arons, Evgeny, et al.
Publicado: (2020) -
Variant B Cell Receptor Isotype Functions Differ in Hairy Cell Leukemia with Mutated BRAF and IGHV Genes
por: Weston-Bell, Nicola J., et al.
Publicado: (2014) -
Vemurafenib and Rituximab in Patients with Hairy Cell Leukemia Previously Treated with Moxetumomab Pasudotox
por: Robak, Tadeusz, et al.
Publicado: (2021)